Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Open, Clinical Study to Evaluate the Safety and Immunogenicity of an Inactivated Split-virion Influenza A(H1N1) Vaccine GC1116 With Adjuvant in Healthy Adults

NCT01201902 is registered in ClinicalTrials.gov with Green Cross Corporation as lead sponsor.

NCT NCT01201902
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01201902 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Open, Clinical Study to Evaluate the Safety and Immunogenicity of an Inactivated Split-virion Influenza A(H1N1) Vaccine GC1116 With Adjuvant in Healthy Adults
Lead sponsor
Green Cross Corporation
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2009
Completion date
July 31, 2010
Enrollment
592 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

influenza infection